Myocardial 6123I9-metaiodobenzylguanidine (MIBG) uptake is different in Parkinson's disease (PD) and multiple system atrophy (MSA) with autonomic failure F. Courbon*, C. Brefel-Courbon**, M.J. Alibelli*, I. Berry*, O. Rascol**, J.L. Montastruc**, J.M. Senard**. *Service de M�decine Nucl�aire, **Service de Pharmacologie Clinique, Centre d'Investigation Clinique H�pitaux de Toulouse, France
Keyword(s):
2006 ◽
Vol 60
(12)
◽
pp. 1542-1547
◽
1997 ◽
Vol 103
(1)
◽
pp. 184
2000 ◽
Vol 15
(6)
◽
pp. 1215-1220
◽
2006 ◽
Vol 243
(1-2)
◽
pp. 57-60
◽
2002 ◽
Vol 73
(6)
◽
pp. 776-776
◽
1999 ◽
Vol 77
(2-3)
◽
pp. 184-189
◽